Last reviewed · How we verify
NCT04190979: ACCESS
Clinical Application of the Medyria TrackCath System in Endovascular Repair of Abdominal Aortic Aneurysms (AAA)
NA trial testing Medyria TrackCath System in Aortic Aneurysm, Abdominal in 40 participants. Completed in 25 February 2019.
25 February 2019
Quick facts
| Lead sponsor | Medyria AG |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 17 March 2018 |
| Primary completion | 25 February 2019 |
| Estimated completion | 25 February 2019 |
| Sites | 4 locations across Germany |
Drugs / interventions tested
- Medyria TrackCath System
Conditions studied
- Aortic Aneurysm, Abdominal — all drugs for Aortic Aneurysm, Abdominal →
- Aortic Aneurysm, Thoracoabdominal — all drugs for Aortic Aneurysm, Thoracoabdominal →
- Acute Renal Failure — all drugs for Acute Renal Failure →
- Acute Kidney Injury — all drugs for Acute Kidney Injury →
Sponsor
Medyria AG
Who can join
18 and older, any sex, with Aortic Aneurysm, Abdominal or Aortic Aneurysm, Thoracoabdominal. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pre-market, single-arm, prospective, open-label, multi-center clinical trial aimed at assessing the safety and the performance of the Medyria TrackCath system in patients undergoing endovascular intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04190979
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aortic Aneurysm, Abdominal
Currently open trials in the same condition.
- NCT06488898 — Abdominal Aortic Aneurysm Stabilization With Truncal Cells: Controlled Clinical Trial With Historical Cohorts · Phase 2 · recruiting
- NCT05972018 — Liposomal Bupivacaine/Bupivacaine in Rectus Sheath Blocks Versus Ropivacaine in Rectus Sheath Blocks And Catheters · Phase 4 · recruiting
- NCT04503395 — ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES · NA · recruiting
- NCT05360108 — Screening for Abdominal Aortic Aneurysm and Popliteal Artery Aneurysm · active not recruiting
- NCT02489539 — Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04190979 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medyria AG
- Last refreshed: 9 December 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04190979.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing